在胰腺癌中免疫抵抗的分子机制:更新

Wei Ming Pang1, Wei Meng Lim2, Zi Ni Ngai3

  • 1School of Health Sciences, IMU University, 57000 Kuala Lumpur, Malaysia.

概括

胰腺癌由于其瘤微环境和分子通路而发展出显著的免疫抵抗力. 了解这些机制对于开发有效的免疫疗法来治疗这种侵袭性疾病至关重要.

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
720